ROVI Corrects English Communication Error

Laboratorios Farmaceuticos Rovi (ES:ROVI) has released an update.

Laboratorios Farmacéuticos ROVI disclosed a correction in its English communication of privileged information due to a material error, ensuring alignment with its authoritative Spanish version. This adjustment underscores the importance of accurate and consistent disclosures in the financial market.

For further insights into ES:ROVI stock, check out TipRanks’ Stock Analysis page.